AGP Limited (AGP): Result Review – By Taurus Research
Oct 23 2025
Taurus Securities
- 3QCY25: – EPS: PKR 3.09, PAT: PKR 911Mn, up 25%YoY/43%QoQ over the SPLY.
- In 3QCY25, AGP’s revenue is expected to clock-in at PKR 6.4Bn, reflecting a 6%YoY and 15%QoQ increase, driven by higher sales volumes amid a seasonal uptick, strong local sales of key brands and deregulation of non-essential drugs. Gross margins are expected to increase 1pptYoY and QoQ to ~60%, supported by higher medicine prices, improved operational efficiency and lower API prices.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low
